A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages

SIMPLE SUMMARY: Due to the lack of progress in OsA’s treatment and survival, there is a need to develop new therapeutic approaches for this tumor. OsA is a complex tumor for which the immune microenvironment appears as a potential therapeutic option. This study explores the antitumor effect of a che...

Descripción completa

Detalles Bibliográficos
Autores principales: Richert, Iseulys, Berchard, Paul, Abbes, Lhorra, Novikov, Alexey, Chettab, Kamel, Vandermoeten, Alexandra, Dumontet, Charles, Karanian, Marie, Kerzerho, Jerome, Caroff, Martine, Blay, Jean-Yves, Dutour, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526955/
https://www.ncbi.nlm.nih.gov/pubmed/37760603
http://dx.doi.org/10.3390/cancers15184635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526955/
https://www.ncbi.nlm.nih.gov/pubmed/37760603
http://dx.doi.org/10.3390/cancers15184635

Ejemplares similares